Agenda at a Glance

There is simply too much going on to present on the website! Please download the brochure for full details. 

Day 1 - February 4, 2020

Biotech


Plenary Keynotes: Towards a sustainable, connected, strategically financed European ecosystem

Morning Break

Capital Markets & Investment
Capital alignment and diversity strategy

Partnerships & Deal Making
M&A & cross industry partnerships

Capital Deployment & Commercialisation Strategy
Regulatory, pricing & advanced therapies

Lunch Break

Early-stage investment strategies & investor alignment 

Late-stage deal-making & win-win partnerships 

Preclinical development strategy & clinical capital deployment

Afternoon Break

Closing Keynotes: Big Pharma Strategy and China R&D

Networking Drinks

Networking Party

Investor Dinner

Medtech


Plenary Keynotes: M&A, consolidations, new value propositions, and commercial leadership in Medtech / unpacking value-based healthcare and multi-stakeholder led value creation

Morning Break

Keynote Panel: The peaks and troughs of the Healthtech investment landscape

Investor Panel: Attracting the big strategics; what CVC need to see

Lunch Break

Afternoon Keynotes: Early-stage fundraising success stories / Tips and tricks for Healthtech partnerships

Afternoon Break

Afternoon Keynotes: Key learnings from the M&A market / The making of Medtech leaders - from fundraising to upscaling

Networking Drinks

Networking Party

Investor Dinner

Showcases


These showcases are for all stages of private and public companies to present news and deal flow or pitch an audience of active investors, pharma, Medtech commercial leaders and big tech.


Biotech Showcases


Lic€n$able Showcases


Medtech Showcases

Full showcase agenda will be released shortly

Forums


By invitation only, the forums run throughout the day one of the Congress for Public CEOs, Pharma BD heads and private growth-stage CEOs.

Public CEO Forum

Pharma BD Forum

Private CEO Forum

Innovation Zone

Startup CEO Forum

find out more

DOWNLOAD FULL AGENDA

Day 2 - February 5, 2020

Biotech


Plenary Keynotes: European Biotech and US Capital

Morning Break

Capital Markets & Investment
Asian investment and public equities

Partnerships & Deal Making
Pharma and platform partnerships

Capital Deployment & Commercialisation Strategy
Self-commercialisation and company building

Lunch Break

Afternoon Keynotes: Health technology convergence - driving the next wave of value in healthcare

Closing Keynotes: Now and then - the true impact of AI on healthcare & realising AI potential

Medtech


Plenary Keynotes: The intersection of digital integration and value-based healthcare / building the IOMT ecosystem; connected devices, refind commercial strategies

Fireside Chat: New Frontiers - taking Asian Medtech global

Morning Break

Keynote Panels: Creating empowered, technologically advanced Healthtech consumers / Innovation, the life-blood of Medtech / Successfully navigating regulatory change; strategic responses to MDR and IVDR

Lunch Break

Afternoon Keynotes: Growing opportunity, growing threat, cyber-security in the context of digitisation / Healthtech’s reimbursement challenge in the digital age

Closing Keynotes: Mapping the Medtech future - new opportunities in collaboration and innovation

Showcases


These showcases are for all stages of private and public companies to present news and deal flow or pitch an audience of active investors, pharma, Medtech commercial leaders and big tech.


Biotech Showcases


Lic€n$able Showcases


Medtech Showcases

Full showcase agenda will be released shortly

Workshops


The workshops are intimate 90-minute interactive education forums. They run throughout day two of the World Congress covering M&A, clinical strategies, licensing & collaboration and market access.

M&A Workshop

Clinical Strategies Workshop

Licensing Workshop

Market Access Workshop

Innovation Zone

find out more

DOWNLOAD FULL AGENDA

Pre-Day - February 3, 2020

LSX IPO Bootcamp (1)


The IPO Bootcamp is a full-day forum in which a team of some of the world’s foremost experts, advisers, bankers and consultants help eight CEOs and CFOs navigate the how, what, where and when of a successful IPO. The key USPs are a very high level and calibre of attendee and program, exclusivity, and a personalised approach. In addition to ‘no holds barred’ discussions, it features tailored sessions, where each registering executive and company received individual attention from the experts to talk through strategy, tactics, mechanics and ideas unique to them.

find out more

DOWNLOAD FULL AGENDA